Bruce Caswell
Analyst · KeyBanc Capital Markets. Please go ahead
Thank you, David. On behalf of the management team, we offer Rick, our deep appreciation for your leadership. You have led Maximus through many accomplishments during your tenure as CFO, including leading our M&A strategy development with six major acquisitions, beginning with Acentia in April 2015, closing a new corporate credit facility and funding the VES acquisition through new debt sources for the company, helping navigate our international growth into new geographies, as we grew from four countries to nine, pushing us to think and operate as a company at scale, including maturing our corporate back office capacity which proved vital to supporting our inorganic and organic growth. Mentoring and sponsoring, many of our rising stars and building a talent pipeline, not only in the finance division but across the company at large and championing our ESG strategy development and advancements. I should note that when we ended FY 2014, we had revenues of $1.7 billion and diluted earnings per share of $2.11. Today, we're reporting $4.25 billion in revenue and diluted EPS of $4.67, a compound growth rate of 14% and 12%, respectively. Your expertise helped us continue our growth as a leading partner to government in the delivery of critical programs on a global scale. Thank you again on behalf of all of us. Since the beginning of FY '21, Maximus has completed four acquisitions, realized several large wins, transitioned leadership in our U.S. Federal segment and more. I will spend my time today talking about the progress we've made toward executing the strategy I've articulated since April 2018. How these four acquisitions support those goals and some refinements we are making to that strategy. On October 6, we closed a contract novation with Navient Corporation which the Department of Education, Federal Student Aid, or FSA, approved on October 20 to begin servicing student loans in January 2022 under the new brand name, Aidvantage. As a long-term partner and provider of consumer engagement services to government, Maximus will focus on the end-to-end borrower experience and help fulfill FSA's mission while remaining independent and conflict free, as we do not and will never provide loan origination, consolidation or collection services. We view student loan servicing as an opportunity to apply our insights, expertise and quality-driven approach through support of both the FSA and the agency's customers, student borrowers. Aidvantage is an extension of a long-standing partnership to support FSA and is in line with our core business. This development demonstrates the availability of increased scope for companies that can successfully manage citizen interactions at scale and our ability to build on trusted relationships with government, a core component of our business model. As you may recall, we have a position on the FSA next-gen contract vehicle to which this work will likely transition in future contract periods. Our immediate priority is to successfully transition the 5.6 million Navient borrower accounts to provide stability and high-quality service, as student loan repayment obligations resume on February 1, 2022. We subsequently will focus on the FSA's stated goals of improving the borrower experience through improved performance, transparency and accountability under the loan servicing contract. To that end, our plan includes implementing best practices and continuous review, performance management and quality monitoring to promote greater transparency and maintain compliance. Again, our role is solely to support student borrowers, as they navigate repayment and for many options related to available authorized loan forgiveness programs. As an independent and conflict free partner to FSA, we will not own, consolidate or originate loans. Meanwhile, the integration of our VES and Attain acquisitions are going as planned, operating as expected and delivering financial results that are consistent with our acquisition analysis. To provide a bit more color, I'm particularly proud of our Attain colleague's recent success, including securing the rebid and expansion of critical work for the Securities and Exchange Commission and supporting the U.S. Customs and Immigration Services client at a critical juncture in their mission. Likewise, our VES colleagues have achieved record volumes recently in scheduling veterans for critical disability benefit evaluations, as that program moves closer to it's pre-pandemic operating model. As for our fourth acquisition in the United Kingdom, I'm pleased to share that Connect Assist, a market-leading provider of citizen engagement centers and digital services has joined Maximus UK. this combination strengthens our program administration capabilities and enables our expansion into adjacent markets, as we previously lacked contact center capabilities in country, a prerequisite for many government procurements. Maximus now employs more than 4,500 people in the United Kingdom, including approximately 1,400 healthcare professionals across more than 270 locations, serving as one of the largest providers of employment, health and disability support program administration in the country. The tireless work of our team this past year resulted in several new contracts and opportunities across the segments. This includes approximately $1.1 billion of COVID response work to help governments respond to the pandemic. Our ability to respond quickly and effectively for our clients has provided the proof points and enhanced our relationships now driving additional work opportunities such as unemployment insurance program support services for several states beyond the pandemic. This fiscal year, we won more new employment services startup work outside the U.S. than we projected. This includes the notable U.K. Restart Program where Maximus provides tailored support to help people back into work. Thus far, thousands of people have been supported by our delivery of the restart program, with nearly 1,500 people finding sustainable employment since we began delivery at the end of June 2021, tracking very favorably against our forecast. Turning to new awards and pipeline as of September 30. For the fourth quarter of fiscal year 2021, full fiscal year signed awards were $5.62 billion of total contract value at September 30. Further, at September 30, there were another $721 million worth of contracts that have been awarded but not yet signed. Of the $5.6 billion of signed work, $3.5 billion represents new work awards with less than $1 billion associated with COVID response work, illustrating a healthy level of new work in our core business. Let me turn our attention to our pipeline of addressable sales opportunities. Our total contract value pipeline at September 30 was $33.9 billion compared to $33.6 billion reported in the third quarter of fiscal 2021. The September 30 pipeline is comprised of approximately $8.8 billion in proposals pending, $1.4 billion in proposals in preparation and $23.7 billion in opportunities tracking. Of the total pipeline, 69% represents new work opportunities. It has been 20 long months since the start of the Public Health Emergency, or PHE. We anticipate that PHE will expire at the end of the first calendar quarter of 2022. With this in mind, as David noted, we expect a solid second half of FY '22 which means, we should exit the year at a strong run rate. Taken together, our view is that the market and company operating dynamics anticipated in the second half of FY '22, create a positive environment and momentum for the business. These dynamics include not just the anticipated conclusion of the PHE and resumption of pre-pandemic activities, including redeterminations but also the startup contracts exiting that phase, new organic wins in U.S. services coming online. The FY '21 acquisitions maturing in their integration and contribution and the benefits of a substantial new work pipeline. I also want to address an area that has received national attention. In September, President Biden signed an executive order requiring U.S.-based employees of federal government contractors to be fully vaccinated against COVID-19, with limited exemptions for medical and religious reasons. Earlier this month, per the President's direction, OSHA also mandated vaccination or weekly testing for employers with 100 or more employees which goes into effect in January 2022. We are planning for implementation of these requirements which includes extensive employee education and resources, paid time off to receive a vaccination and frequent reminders regarding time lines and options. As we have throughout the pandemic, we have prioritized employee safety and well-being and we actively monitor guidance and update our procedures accordingly. Demand for talent is highly competitive. Our implementation of these requirements may result in some workforce attrition and difficulty meeting our existing or future hiring needs. That being said, Maximus has a strong talent brand that was, if anything, strengthened as a key differentiator over the past 20 months, with the many benefits and programs we quickly implemented to support and protect our people. During FY '21, we hired more than 42,000 employees around the world. Our recruiting programs focus on identifying and evaluating talent through practices that welcome a diverse workforce, including veterans, people with disabilities, language barriers and those from varying socioeconomic backgrounds. To support the training and development of our employees, over 165,000 online learning resources and tools are available, in addition to other development opportunities. We continue to operate in a hybrid environment, recognizing that some employees are required to be on-site due to customer requirements. We are imagining new ways of working that put us in an even better position over the long-term to attract the necessary talent for our business through workplace flexibility and outside of historical geographical bounds. On a final note, I'm pleased that our execution on our three pronged strategy of expanding our clinical business, driving digital transformation for our customers and the citizens we serve and expanding to adjacent markets has successfully led to balanced organic and inorganic growth since I became CEO and set the table for future organic growth in our expanded core and new markets. With this as the backdrop and our current focus on delivering shareholder value through our FY '21 acquisitions we have concurrently kicked off a 3-year to 5-year strategy refresh initiative with participation from across the business. Not only do we seek to define what the next phase in our clinical and technology journey will look like but we are looking further over the horizon than we would in our annual planning process. I'm excited about the energy and ideas that this collaborative process has already yielded and look forward to sharing more formal insights with our shareholders and the analyst community during our planned Investor Day in 2022. And with that, we will open the line for Q&A. Operator?